Results 201 to 210 of about 11,313 (238)
Some of the next articles are maybe not open access.
Corneal Collagen Cross-linking
American Journal of Ophthalmology, 2012Corneal collagen cross-linking has recently emerged as a novel approach for management of ectasia. This article reviews the literature published in the past 3 years about the expanding spectrum of cross-linking as a therapeutic modality and its complications.Recent studies have confirmed the beneficial effects of cross-linking in stabilization and to a
Kunal, Suri +2 more
openaire +4 more sources
Expanding indications for corneal cross-linking
Current Opinion in Ophthalmology, 2023Purpose of review The aim of this study was to summarize the recent developments in corneal cross-linking (CXL) and its indications, including corneal ectasias, refractive surgery and infectious keratitis. Recent findings Advances in ...
Farhad, Hafezi +2 more
openaire +2 more sources
Corneal Cross Linking for Keratoconus
Seminars in Ophthalmology, 2010Riboflavin-induced ultraviolet light (UV) cross linking has received a significant amount of attention in recent years. It is currently approved in Europe as a treatment for keratoconus and is also being used for other corneal disorders. The goal of this paper is to review in detail seminal papers and studies that have been done to support cross ...
Anne, Keating +2 more
openaire +2 more sources
2021
Corneal cross-linking was first introduced in 2003 as a novel approach to halt progression of corneal ectasia. Adopted early, and widely used abroad, the FDA approved a drug device combination product for corneal cross-linking in the United States in 2016.
Stephen Tse +2 more
openaire +1 more source
Corneal cross-linking was first introduced in 2003 as a novel approach to halt progression of corneal ectasia. Adopted early, and widely used abroad, the FDA approved a drug device combination product for corneal cross-linking in the United States in 2016.
Stephen Tse +2 more
openaire +1 more source
Corneal cross-linking in the treatment of corneal ulcers
Current Opinion in Ophthalmology, 2016New treatments for corneal ulcers are needed to address challenges with antibiotic resistance, cost, and specificity requiring timely pathogen identification. This review assesses the evidence regarding safety and efficacy of corneal cross-linking (CXL) as an adjunct or stand-alone treatment.To date approximately 200 clinical cases of CXL used with ...
Marianne O, Price, Francis W, Price
openaire +2 more sources
Accelerated Corneal Cross-Linking
2018Purpose: Corneal cross-linking (CXL) is a relatively new treatment that offers refractive stability in patients with corneal ectatic disorders. The conventional Dresden protocol has been firstly described, and its effectiveness has been demonstrated by several clinical trials.
Leopoldo Spadea +3 more
openaire +2 more sources
Customized Corneal Cross-Linking
2018Personalized accelerated crosslinking nomograms for the management of corneal ectasia were conceived after comparative analysis of demarcation lines and cell viability observed after customized accelerated epithelium-off crosslinking CXL treatments by spectral domain corneal OCT and scanning laser in vivo confocal microscopy matching all the clinical ...
Mazzotta C., Rechichi M., Ferrise M.
openaire +3 more sources
Expert Review of Ophthalmology, 2014
Corneal collagen cross-linking (CXL) entails the use of ultraviolet light with a cross-linking agent to form cross bridges in the corneal collagen fibers with subsequent strengthening of the corneal stroma. CXL was first reported on humans in 2003 for patients with keratoconus.
Majed Alkharashi +2 more
openaire +1 more source
Corneal collagen cross-linking (CXL) entails the use of ultraviolet light with a cross-linking agent to form cross bridges in the corneal collagen fibers with subsequent strengthening of the corneal stroma. CXL was first reported on humans in 2003 for patients with keratoconus.
Majed Alkharashi +2 more
openaire +1 more source
Corneal Cross-linking at the Slit Lamp
Journal of Refractive Surgery, 2021PURPOSE: To describe a new surgical technique where corneal cross-linking (CXL) (to treat corneal ectasias) and photo-activated chromophore for keratitis-CXL (PACK-CXL) are performed while the patient is seated in an upright position at the slit lamp.
Farhad, Hafezi +4 more
openaire +2 more sources
Riboflavin for corneal cross-linking
Drugs of Today, 2016Corneal collagen cross-linking (CXL) with riboflavin and ultraviolet A (UVA) radiation is the first therapeutic modality that appears to arrest the progression of keratoconus and other corneal ectasias. Riboflavin is central to the process, acting as a photosensitizer for the production of oxygen singlets and riboflavin triplets.
openaire +2 more sources